These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Clostridium perfringens enterotoxin as a novel-targeted therapeutic for brain metastasis. Kominsky SL; Tyler B; Sosnowski J; Brady K; Doucet M; Nell D; Smedley JG; McClane B; Brem H; Sukumar S Cancer Res; 2007 Sep; 67(17):7977-82. PubMed ID: 17804705 [TBL] [Abstract][Full Text] [Related]
29. A Method to Prepare Claudin-Modulating Recombinant Proteins. Tachibana K; Kondoh M Methods Mol Biol; 2020; 2109():251-260. PubMed ID: 31471875 [TBL] [Abstract][Full Text] [Related]
30. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. Fujita K; Katahira J; Horiguchi Y; Sonoda N; Furuse M; Tsukita S FEBS Lett; 2000 Jul; 476(3):258-61. PubMed ID: 10913624 [TBL] [Abstract][Full Text] [Related]
31. Clostridium perfringens enterotoxin as a potential drug for intravesical treatment of bladder cancer. Gabig TG; Waltzer WC; Whyard T; Romanov V Biochem Biophys Res Commun; 2016 Sep; 478(2):887-92. PubMed ID: 27520378 [TBL] [Abstract][Full Text] [Related]
32. A synthetic peptide corresponding to the extracellular loop 2 region of claudin-4 protects against Clostridium perfringens enterotoxin in vitro and in vivo. Shrestha A; Robertson SL; Garcia J; Beingasser J; McClane BA; Uzal FA Infect Immun; 2014 Nov; 82(11):4778-88. PubMed ID: 25156725 [TBL] [Abstract][Full Text] [Related]
33. Reversible opening of the blood-brain barrier by claudin-5-binding variants of Clostridium perfringens enterotoxin's claudin-binding domain. Neuhaus W; Piontek A; Protze J; Eichner M; Mahringer A; Subileau EA; Lee IM; Schulzke JD; Krause G; Piontek J Biomaterials; 2018 Apr; 161():129-143. PubMed ID: 29421550 [TBL] [Abstract][Full Text] [Related]
34. Directed structural modification of Clostridium perfringens enterotoxin to enhance binding to claudin-5. Protze J; Eichner M; Piontek A; Dinter S; Rossa J; Blecharz KG; Vajkoczy P; Piontek J; Krause G Cell Mol Life Sci; 2015 Apr; 72(7):1417-32. PubMed ID: 25342221 [TBL] [Abstract][Full Text] [Related]
35. Human claudin-8 and -14 are receptors capable of conveying the cytotoxic effects of Clostridium perfringens enterotoxin. Shrestha A; McClane BA mBio; 2013 Jan; 4(1):. PubMed ID: 23322640 [TBL] [Abstract][Full Text] [Related]
36. Fine mapping of the N-terminal cytotoxicity region of Clostridium perfringens enterotoxin by site-directed mutagenesis. Smedley JG; McClane BA Infect Immun; 2004 Dec; 72(12):6914-23. PubMed ID: 15557612 [TBL] [Abstract][Full Text] [Related]
37. Specific binding of Clostridium perfringens enterotoxin fragment to Claudin-b and modulation of zebrafish epidermal barrier. Zhang J; Ni C; Yang Z; Piontek A; Chen H; Wang S; Fan Y; Qin Z; Piontek J Exp Dermatol; 2015 Aug; 24(8):605-10. PubMed ID: 25869230 [TBL] [Abstract][Full Text] [Related]
39. [Non-invasive drug delivery system with the claudin binder]. Takahashi A; Kondoh M; Yagi K Yakugaku Zasshi; 2011; 131(11):1583-7. PubMed ID: 22041696 [TBL] [Abstract][Full Text] [Related]
40. Effects of Claudin-1 on the Action of Mehdizadeh Gohari I; Li J; Navarro M; Uzal F; McClane B Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31601044 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]